$CEVA
CEVA INC Stock $ceva

$ceva Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000143774919003949 Filed on March 04, 2019

Income Statement

Concept	2017 Q4	2016 Q4	2016
Revenue	$21.60M	$21.20M	$72.65M
YoY Change	1.89%	31.92%	22.11%
Cost Of Revenue	$1.920M	$1.630M	$6.086M
YoY Change	17.79%	15.6%	12.21%
Gross Profit	$19.68M	$19.56M	$66.57M
YoY Change	0.61%	33.42%	23.1%
Gross Profit Margin	91.11%	92.26%	91.62%
Selling, General & Admin	$6.250M	$5.360M	$20.11M
YoY Change	16.6%	3.68%	9.56%
% of Gross Profit	31.76%	27.4%	30.21%
Research & Development	$9.970M	$7.770M	$30.84M
YoY Change	28.31%	11.96%	9.69%
% of Gross Profit	50.66%	39.72%	46.33%
Depreciation & Amortization	$870.0K	$710.0K	$1.399M
YoY Change	22.54%	16.39%	32.23%
% of Gross Profit	4.42%	3.63%	2.1%
Operating Expenses	$16.53M	$13.44M	$52.18M
YoY Change	22.99%	8.13%	9.25%
Operating Profit	$3.150M	$6.120M	$14.39M
YoY Change	-48.53%	174.44%	127.92%
Interest Expense	$880.0K	$420.0K	$2.000M
YoY Change	109.52%	0.0%	66.67%
% of Operating Profit	27.94%	6.86%	13.9%
Other Income/Expense, Net		$0.00	$0.00
YoY Change			-100.0%
Pretax Income	$4.030M	$6.550M	$16.43M
YoY Change	-38.47%	147.17%	122.53%
Income Tax	$860.0K	$1.350M	$3.325M
% Of Pretax Income	21.34%	20.61%	20.24%
Net Earnings	$3.160M	$5.200M	$13.10M
YoY Change	-39.23%	126.09%	109.03%
Net Earnings / Revenue	14.63%	24.53%	18.03%
Basic Earnings Per Share			$0.63
Diluted Earnings Per Share	$138.6K	$235.5K	$0.61
COMMON SHARES
Basic Shares Outstanding	21.97M shares	21.23M shares	20.85M
Diluted Shares Outstanding			21.57M

Balance Sheet

Concept	2017 Q4	2016 Q4	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$104.4M	$80.27M	$126.5M
YoY Change	30.07%	19.49%	29.21%
Cash & Equivalents	$21.74M	$18.40M	$18.40M
Short-Term Investments	$82.66M	$61.87M	$108.1M
Other Short-Term Assets	$3.700M	$3.100M	$3.100M
YoY Change	19.35%	-22.5%	-22.5%
Inventory
Prepaid Expenses
Receivables	$16.49M	$15.04M	$15.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$159.1M	$144.7M	$144.7M
YoY Change	9.93%	36.49%	36.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.926M	$4.805M	$4.800M
YoY Change	44.14%	28.79%	29.73%
Goodwill	$46.61M	$46.61M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$49.90M	$33.20M	$33.20M
YoY Change	50.3%	-22.97%	-22.97%
Other Assets	$3.579M	$1.412M	$10.20M
YoY Change	153.47%	-21.82%	14.61%
Total Long-Term Assets	$117.7M	$97.78M	$97.80M
YoY Change	20.41%	-8.29%	-8.26%
TOTAL ASSETS
Total Short-Term Assets	$159.1M	$144.7M	$144.7M
Total Long-Term Assets	$117.7M	$97.78M	$97.80M
Total Assets	$276.8M	$242.5M	$242.5M
YoY Change	14.15%	14.04%	14.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$400.0K	$600.0K	$600.0K
YoY Change	-33.33%	-14.29%	-14.29%
Accrued Expenses	$3.927M	$4.015M	$13.10M
YoY Change	-2.19%	10.51%	-3.68%
Deferred Revenue	$4.399M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$22.80M	$22.60M	$22.60M
YoY Change	0.89%	19.03%	18.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.300M	$8.300M	$8.300M
YoY Change	12.05%	9.21%	9.21%
Total Long-Term Liabilities	$9.300M	$8.300M	$8.300M
YoY Change	12.05%	9.21%	9.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.80M	$22.60M	$22.60M
Total Long-Term Liabilities	$9.300M	$8.300M	$8.300M
Total Liabilities	$32.10M	$30.90M	$30.90M
YoY Change	3.88%	16.17%	16.17%
SHAREHOLDERS EQUITY
Retained Earnings	$53.87M	$39.43M
YoY Change	36.63%	33.45%
Common Stock	$217.4M	$212.1M
YoY Change	2.51%	1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$26.06M	$39.51M
YoY Change	-34.05%	-23.73%
Treasury Stock Shares	$1.531M	2.322M shares
Shareholders Equity	$244.7M	$211.6M	$211.6M
YoY Change
Total Liabilities & Shareholders Equity	$276.8M	$242.5M	$242.5M
YoY Change	14.15%	14.04%	14.06%

Cashflow Statement

Concept	2017 Q4	2016 Q4	2016
OPERATING ACTIVITIES
Net Income	$3.160M	$5.200M	$13.10M
YoY Change	-39.23%	126.09%	109.03%
Depreciation, Depletion And Amortization	$870.0K	$710.0K	$1.399M
YoY Change	22.54%	16.39%	32.23%
Cash From Operating Activities	$6.770M	$12.49M	$14.46M
YoY Change	-45.8%	7.95%	-25.39%
INVESTING ACTIVITIES
Capital Expenditures	-$800.0K	-$360.0K	$2.387M
YoY Change	122.22%	-64.36%	9.29%
Acquisitions
YoY Change
Other Investing Activities	-$7.770M	-$14.22M	-$18.64M
YoY Change	-45.36%	92.94%	149.87%
Cash From Investing Activities	-$8.570M	-$14.58M	-$21.03M
YoY Change	-41.22%	73.78%	117.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.417M
YoY Change			-66.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	590.0K	620.0K	6.198M
YoY Change	-4.84%	-205.08%	-189.18%
NET CHANGE
Cash From Operating Activities	6.770M	12.49M	14.46M
Cash From Investing Activities	-8.570M	-14.58M	-21.03M
Cash From Financing Activities	590.0K	620.0K	6.198M
Net Change In Cash	-1.210M	-1.470M	-373.0K
YoY Change	-17.69%	-156.76%	-113.42%
FREE CASH FLOW
Cash From Operating Activities	$6.770M	$12.49M	$14.46M
Capital Expenditures	-$800.0K	-$360.0K	$2.387M
Free Cash Flow	$7.570M	$12.85M	$12.07M
YoY Change	-41.09%	2.15%	-29.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1155000
CY2017Q4	ceva	Accrued Engineering Costs Current AccruedEngineeringCostsCurrent	977000
CY2018Q4	ceva	Accrued Engineering Costs Current AccruedEngineeringCostsCurrent	884000
CY2017Q4	ceva	Accrued Expenses Intangible Assets AccruedExpensesIntangibleAssets
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001173489
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018	dei	Entity Registrant Name EntityRegistrantName	CEVA INC
CY2018	dei	Trading Symbol TradingSymbol	ceva
CY2018Q4	ceva	Accrued Expenses Intangible Assets AccruedExpensesIntangibleAssets	750000
CY2017Q4	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	9347000
CY2018Q4	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	9632000
CY2017	ceva	Amortization Of Intangible Assets Including Portion In Cost Of Revenues AmortizationOfIntangibleAssetsIncludingPortionInCostOfRevenues	1236000
CY2018	ceva	Amortization Of Intangible Assets Including Portion In Cost Of Revenues AmortizationOfIntangibleAssetsIncludingPortionInCostOfRevenues	1242000
CY2018Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains	134000
CY2017Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains	14000
CY2018Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss	1325000
CY2017Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss	683000
CY2018Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Gains AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
CY2017Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Gains AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains	3000
CY2018Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Loss AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss	32000
CY2017Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Loss AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss	12000
CY2018	ceva	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
CY2017Q4	ceva	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Deferred Revenues DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndDeferredRevenues	1057000
CY2018Q4	ceva	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Deferred Revenues DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndDeferredRevenues	1274000
CY2018	ceva	Defined Contribution Plan Contribution Rate DefinedContributionPlanContributionRate	0.1
CY2016	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.13
CY2017	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.12
CY2018	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.01
CY2016	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI
CY2017	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI
CY2018	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI	880000
CY2018Q4	ceva	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	289000
CY2017Q4	ceva	Grant Payable GrantPayable	791000
CY2018Q4	ceva	Grant Payable GrantPayable	417000
CY2018	ceva	Impact Of Adoption Of Accounting Standards Update ImpactOfAdoptionOfAccountingStandardsUpdate	8555000
CY2016	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	505000
CY2017	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	-1757000
CY2018	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	16000
CY2016	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	505000
CY2017	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	529000
CY2018	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	434000
CY2016	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	2767000
CY2017	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	2698000
CY2018	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	239000
CY2016	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	538000
CY2017	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	737000
CY2018	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	563000
CY2016	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	10966000
CY2017	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	1446000
CY2018	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	463000
CY2016	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	195000
CY2017	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	-151000
CY2018	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	557000
CY2016	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	94000
CY2017	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	-1807000
CY2018	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	527000
CY2016	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	134000
CY2017	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	-21000
CY2018	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	215000
CY2016	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-613000
CY2017	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-1375000
CY2018	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-2187000
CY2016	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid
CY2017	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid
CY2018	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid	750000
CY2016	ceva	Investment In Bank Deposits InvestmentInBankDeposits	41476000
CY2017	ceva	Investment In Bank Deposits InvestmentInBankDeposits	47027000
CY2018	ceva	Investment In Bank Deposits InvestmentInBankDeposits	21596000
CY2017Q4	ceva	Longterm Bank Deposits LongtermBankDeposits	44518000
CY2018Q4	ceva	Longterm Bank Deposits LongtermBankDeposits	21864000
CY2018Q4	ceva	Other Longterm Investments Fair Value OtherLongtermInvestmentsFairValue	936000
CY2016	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	37594000
CY2017	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	44450000
CY2018	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	32892000
CY2016	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	6410000
CY2017Q4	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	4137000
CY2018	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	3352000
CY2016	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	1485000
CY2017	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	1555000
CY2018	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	2065000
CY2018	ceva	Sales Commission Expected Amortization Period Within Which The Sales Commission Fee Is Expensed When Incurred SalesCommissionExpectedAmortizationPeriodWithinWhichTheSalesCommissionFeeIsExpensedWhenIncurred	P1Y
CY2017Q4	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	8910000
CY2018Q4	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	9026000
CY2016	ceva	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeiture
CY2016	ceva	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture For Executives ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureForExecutives	0.05
CY2018Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageExercisePrice	19.14
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm	P4Y
CY2016	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	12282000
CY2017	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	15188000
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	384000
CY2017	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2017Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	729017
CY2018Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	702817
CY2018Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice	19.88
CY2013Q4	ceva	Share Repurchase Program Additional Number Of Shares Authorized To Be Repurchased ShareRepurchaseProgramAdditionalNumberOfSharesAuthorizedToBeRepurchased	4000000
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueExercisable	2648000
CY2017Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	19229000
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	2708000
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Execisable Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExecisableWeightedAverageRemainingContractualTerms	P4Y
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercisable Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisableNumber	623718
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercised In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisedInPeriod	-22530
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercised Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisedWeightedaverageExercisePrice	16.07
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeited Or Expired In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeitedOrExpiredInPeriod	-3670
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeited Or Expired Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeitedOrExpiredWeightedaverageExercisePrice	22.67
CY2017	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P5Y73D
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P4Y109D
CY2017Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	19.77
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	19.88
CY2017Q4	ceva	Shortterm Bank Deposits ShorttermBankDeposits	34432000
CY2018Q4	ceva	Shortterm Bank Deposits ShorttermBankDeposits	46139000
CY2016	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit
CY2017	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit	1916000
CY2018	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit	3542000
CY2017	ceva	Tax Cuts And Jobs Act Of2017 Transition Tax Income Tax Expense Benefit TaxCutsAndJobsActOf2017TransitionTaxIncomeTaxExpenseBenefit	16053000
CY2018	ceva	Technical Support Period TechnicalSupportPeriod	P1Y
CY2016	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	9615000
CY2017	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	7487000
CY2018	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	2249000
CY2016	ceva	Treasury Stock Value Acquired Weighted Average Method TreasuryStockValueAcquiredWeightedAverageMethod	3417000
CY2018	ceva	Treasury Stock Value Acquired Weighted Average Method TreasuryStockValueAcquiredWeightedAverageMethod	20008000
CY2017	ceva	Unrecognized Tax Benefits Decreases Resulting From Tax Audit Completion UnrecognizedTaxBenefitsDecreasesResultingFromTaxAuditCompletion	3003000
CY2018	ceva	Unrecognized Tax Benefits Decreases Resulting From Tax Audit Completion UnrecognizedTaxBenefitsDecreasesResultingFromTaxAuditCompletion
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22063490
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q2	dei	Entity Public Float EntityPublicFloat	498330000
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1236000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	392000
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	632000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26156000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16494000
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	45000
CY2018Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	141000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3927000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4344000
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	792000
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	752000
CY2017Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	290000
CY2018Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	259000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10197000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12799000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-586000
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1114000
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	217417000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	223250000
CY2016	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1236000
CY2017	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1236000
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1242000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6236000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8693000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10367000
CY2016	us-gaap	Advertising Expense AdvertisingExpense	1033000
CY2017	us-gaap	Advertising Expense AdvertisingExpense	1118000
CY2018	us-gaap	Advertising Expense AdvertisingExpense	1080000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6236000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8693000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10367000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1236000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	901000
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	282696
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29892
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	161362
CY2017Q4	us-gaap	Assets Assets	276812000
CY2018Q4	us-gaap	Assets Assets	277263000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	159076000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	177288000
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	117736000
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	99975000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	134000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1357000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	695000
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	78692000
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	83342000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1165000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	284000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	192000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	411000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	16580000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	49921000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	52590000
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	22960000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	72598000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	71539000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	71407000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	70870000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	6094000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	11803000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	6062000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	11794000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	82664000
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	77469000
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-9000
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0
CY2018	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-67000
CY2016	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	24000
CY2017	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	47000
CY2018	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4000
CY2016	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	33000
CY2017	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	47000
CY2018	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	71000
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	86000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	14000
CY2018Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	223000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18909000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18401000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21739000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22260000
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-508000
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3338000
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	521000
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21787860
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22064007
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	22000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	22000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13022000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16939000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	46000
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of credit risk</div></div><div style="display: inline; font-style: italic;">:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be redeemed on demand and therefore minimal credit risk exists with respect to them.   Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. While the Company monitors on a systematic basis the cash and cash equivalent balances in the operating accounts and adjust the balances as appropriate, these balances could be impacted if <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more of the financial institutions with which the Company deposit its funds fails or is subject to other adverse conditions in the financial or credit markets. To date the Company has experienced <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> loss of principal or lack of access to its invested cash or cash equivalents; however, the Company can provide <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that access to its invested cash and cash equivalents will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be affected if the financial institutions in which the Company holds its cash and cash equivalents fail. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the Company believes the losses associated with its investments are temporary and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impairment loss was recognized during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> However, the Company can provide <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that it will recover declines in the market value of its investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company is exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be adversely impacted, whereas a decline in interest rates <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>decrease the anticipated interest income for variable rate investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company is exposed to financial market risks, including changes in interest rates. The Company typically does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> attempt to reduce or eliminate its market exposures on its investment securities because the majority of its investments are short-term.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and to date has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any material losses. The Company makes judgments on its ability to collect outstanding receivables and provides allowances for the portion of receivables for which collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding receivables. In determining the provision, the Company considers the expected collectability of receivables.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> off-balance-sheet concentration of credit risk.</div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4399000
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3593000
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3728000
CY2018Q4	us-gaap	Contractual Obligation ContractualObligation	5670000
CY2018Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	33000
CY2018Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	3779000
CY2018Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	1624000
CY2018Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	234000
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	1806000
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	6086000
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	6953000
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	7951000
CY2016	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	0
CY2017	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	0
CY2018	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	8555000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-227000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3932000
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3473000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2913000
CY2016	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-9000
CY2017	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss
CY2018	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-67000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-613000
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1375000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2187000
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	309000
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	114000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20542000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18783000
CY2017Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2118000
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3194000
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	3643000
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	5924000
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3952000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6038000
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3643000
CY2018Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	5924000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13069000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9505000
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	476000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1866000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1381000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1956000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2724000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16590000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12745000
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	705000
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.15
CY2017	us-gaap	Depreciation Depreciation	2014000
CY2018	us-gaap	Depreciation Depreciation	2915000
CY2016	us-gaap	Depreciation Depreciation	1399000
CY2016	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	161000
CY2017	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	189000
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-354000
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	275000
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	114000
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	34000
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1020000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	988000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1048000
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-135000
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	168000
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-159000
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14077000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13183000
CY2017Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1806000
CY2018Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	936000
CY2018Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	870000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4419000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5661000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	314000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6161000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	314000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	314000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	314000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8361000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2700000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1742000
CY2017Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure
CY2018Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	77000
CY2018Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	77000
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-188000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-241000
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-75000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	42000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-155000
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8567000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10488000
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10354000
CY2017Q4	us-gaap	Goodwill Goodwill	46612000
CY2018Q4	us-gaap	Goodwill Goodwill	46612000
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2016	us-gaap	Gross Profit GrossProfit	66567000
CY2017	us-gaap	Gross Profit GrossProfit	80554000
CY2018	us-gaap	Gross Profit GrossProfit	69926000
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2018	us-gaap	Impairment Of Investments ImpairmentOfInvestments	870000
CY2017	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2016	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2017	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2016	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2018	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3488000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5946000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5680000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16425000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18899000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1303000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	16425000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	19913000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	24845000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6983000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18899000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1303000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3325000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1871000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	729000
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1212000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2076000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5005000
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1831000
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2304000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	369000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5585000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	6426000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	274000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	682000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	294000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	217000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1503000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-62000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-94000
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-787000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	608000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3287000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5203000
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4294000
CY2016	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-190000
CY2017	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-184000
CY2018	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	226000
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	668000
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1493000
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	96000
CY2016	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3495000
CY2017	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1859000
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-806000
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-277000
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1259000
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-493000
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	622000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2478000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3855000
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	715000
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	790000
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	469000
CY2016	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1064000
CY2017	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1179000
CY2018	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	773000
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	3300000
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4233000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	4499000
CY2016	us-gaap	Investment Income Net InvestmentIncomeNet	2039000
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	3026000
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	3418000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276812000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277263000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22795000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21752000
CY2017Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	9347000
CY2018Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	9632000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6198000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7487000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17759000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21030000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28786000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9827000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14459000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24469000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8612000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	13100000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	17028000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	574000
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2018	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2016	us-gaap	Operating Expenses OperatingExpenses	52181000
CY2017	us-gaap	Operating Expenses OperatingExpenses	64681000
CY2018	us-gaap	Operating Expenses OperatingExpenses	71171000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	14386000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	15873000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-1245000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1259000
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1417000
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1481000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3579000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5569000
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-86000
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-99000
CY2018	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-545000
CY2016	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-89000
CY2017	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-105000
CY2018	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-622000
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	-3000
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	-6000
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	-77000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-78000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-89000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-528000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-9000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
CY2018	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-94000
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-67000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	161000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	189000
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	-354000
CY2016	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-11000
CY2017	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-16000
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	158000
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	183000
CY2018	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-431000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-95000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-99000
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-612000
CY2018	us-gaap	Other General Expense OtherGeneralExpense	59010000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1032000
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1141000
CY2017Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1806000
CY2018Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	936000
CY2016	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2017	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2018	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3417000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20008000
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	43537000
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	54882000
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	19666000
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1960000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2387000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4135000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3319000
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5264000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3747000
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	9615000
CY2016	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	8022000
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9296000
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7487000
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2249000
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10122000
CY2016	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	20754000
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	23512000
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	13354000
CY2016	us-gaap	Profit Loss ProfitLoss	13100000
CY2017	us-gaap	Profit Loss ProfitLoss	17028000
CY2018	us-gaap	Profit Loss ProfitLoss	574000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17123000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20143000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6926000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7344000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30838000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40385000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47755000
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3948000
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1500000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62853000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	53873000
CY2016	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	72653000
CY2017	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	87507000
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	77877000
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12567000
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2008Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000
CY2018Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	355180
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	186095000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	211551000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	244670000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	245879000
CY2016	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	18.98
CY2018	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	30.51
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1531153
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1807300
CY2016	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	180013
CY2017	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	655876
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	26056000
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	39132000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2224000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2739000
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3784000
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	60000
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11540000
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12572000
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12161000
CY2016	us-gaap	Severance Costs1 SeveranceCosts1	1348000
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	1413000
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	1818000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	6236000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	8693000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10367000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.49
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.38
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.024
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.005
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.90
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1188000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	575000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	255000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of estimates</div></div><div style="display: inline; font-style: italic;">:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	25000
CY2018	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense
CY2018	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	25000
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21565000
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22561000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22503000
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20850000
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21771000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22034000

Files In Submission

Name	View Source	Status
0001437749-19-003949-index-headers.html	Edgar Link	pending
0001437749-19-003949-index.html	Edgar Link	pending
0001437749-19-003949.txt	Edgar Link	pending
0001437749-19-003949-xbrl.zip	Edgar Link	pending
ceva-20181231.xml	Edgar Link	completed
ceva-20181231.xsd	Edgar Link	pending
ceva-20181231_cal.xml	Edgar Link	unprocessable
ceva-20181231_def.xml	Edgar Link	unprocessable
ceva-20181231_lab.xml	Edgar Link	unprocessable
ceva-20181231_pre.xml	Edgar Link	unprocessable
ceva20181231_10k.htm	Edgar Link	pending
ex_136236.htm	Edgar Link	pending
ex_136237.htm	Edgar Link	pending
ex_136238.htm	Edgar Link	pending
ex_136239.htm	Edgar Link	pending
ex_136240.htm	Edgar Link	pending
eylogo.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEVA
CEVA INC Stock $ceva

2017 Q4 Form 10-K Financial Statement

#000143774919003949 Filed on March 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA CEVA INC Stock $ceva

2017 Q4 Form 10-K Financial Statement

#000143774919003949 Filed on March 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA
CEVA INC Stock $ceva